Skip to main content
editorial
. 2021 Jun;10(6):2828–2831. doi: 10.21037/tau-20-1321

Figure 1.

Figure 1

Identification, detection and active surveillance according to a one-size-fits-all approach (traditional, upper part of the figure) and an individual dynamic risk-based approach (future, lower part of the figure). PSA, prostate-specific antigen; DRE, digital rectal examination.